Holen Sie sich die Stockscreener-App
27.36
0.85%
0.225
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RARE?
Forum
Prognose
Aktiensplit
Ultragenyx Pharmaceutical Inc Aktie (RARE) Neueste Nachrichten
Ultragenyx Pharmaceutical Inc. (RARE) Gets FDA CRL for UX111, Vows Quick Resubmission - Insider Monkey
Why Ultragenyx Pharmaceutical Inc. stock attracts strong analyst attentionSummary of Reliable Long-Term Trade Models - Newser
Ultragenyx Pharmaceutical Inc. stock trendline breakdownHigh Return Trade Roadmap with Setup Filters - Newser
Is Ultragenyx Pharmaceutical Inc. stock overvalued or undervaluedAI Powered Review For 2025 - jammulinksnews.com
Ultragenyx Pharmaceutical Inc. (RARE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update - GlobeNewswire
Ultragenyx's Strategic Momentum: Catalyzing Long-Term Value Through Revenue Growth and Gene Therapy Innovation - AInvest
Ultragenyx Pharmaceutical Inc. to Host Conference Call for Q2 2025 Financial Results and Corporate Update - Quiver Quantitative
Rare Disease Leader Ultragenyx Sets Q2 2025 Earnings Call: Key Updates Expected for Genetic Disease Pipeline - Stock Titan
Ultragenyx Pharmaceutical Inc. stock momentum explainedWeekly Portfolio Update with ROI Focus - Newser
Ultragenyx Pharmaceutical Inc. Shows Early Signs of Technical StrengthTriple Digit Growth Focused Trade Plan Reviewed - beatles.ru
Ultragenyx: July Selloff Creates Buying Opportunity Ahead Of UX143 Catalyst (NASDAQ:RARE) - Seeking Alpha
Custom strategy builders for tracking Ultragenyx Pharmaceutical Inc.Free Daily Momentum Screener With Alerts - Newser
Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by Analysts at HC Wainwright - Defense World
Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks - Benzinga
Does Ultragenyx Pharmaceutical Inc. stock perform well during market downturnsExpert guidance for superior capital growth - jammulinksnews.com
Ultragenyx Pharma stock rating initiated at Buy by H.C. Wainwright - Investing.com
What is the dividend policy of Ultragenyx Pharmaceutical Inc. stockCapitalize on proven investment strategies - jammulinksnews.com
What institutional investors are buying Ultragenyx Pharmaceutical Inc. stockCapitalize on proven investment strategies - jammulinksnews.com
How hedge fund analytics apply to Ultragenyx Pharmaceutical Inc. stockReal-Time AI Generated Market Forecast - Newser
Visual trend scoring systems applied to Ultragenyx Pharmaceutical Inc.Free Growth Focused Entry Plan Suggestions - Newser
Ultragenyx Pharmaceutical Inc. stock trendline breakdown Capital Protection Strategy With Risk Analysis - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc.RARE - PR Newswire
What catalysts could drive Ultragenyx Pharmaceutical Inc. stock higher in 2025Free Daily Trading Room Entry - jammulinksnews.com
How does Ultragenyx Pharmaceutical Inc. compare to its industry peersMaximize your portfolio’s earning potential - jammulinksnews.com
How strong is Ultragenyx Pharmaceutical Inc. company’s balance sheetGet real-time alerts on high-potential stocks - jammulinksnews.com
How Ultragenyx Pharmaceutical Inc. stock performs during market volatilityElite Stock Shortlist - Newser
New Product Launches: Will They Boost Ultragenyx Pharmaceutical Inc. Stock in 2025Top Rated Trade Entries - Newser
How Resilient Is Ultragenyx Pharmaceutical Inc. Stock During Economic DownturnsCarefully Curated High Return Stocks - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Ultragenyx Pharmaceutical Inc. (RARE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Will Ultragenyx Pharmaceutical Inc. stock split in the near futureTurbocharged investment results - jammulinksnews.com
What analysts say about Ultragenyx Pharmaceutical Inc. stockFree Trend-Following Techniques - Autocar Professional
Ultragenyx Pharmaceutical Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - Autocar Professional
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical, - openPR.com
Ultragenyx Pharmaceutical Inc. (RARE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What drives Ultragenyx Pharmaceutical Inc. stock priceRapid portfolio appreciation - Autocar Professional
RARE ALERT: Levi & Korsinsky Investigates Ultragenyx Pharmaceutical Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
RARE ACTIVE INVESTIGATION: Lost Money on Ultragenyx Pharmaceutical Inc.? Contact Levi & Korsinsky Now - ACCESS Newswire
Ultragenyx Pharmaceutical (RARE) Gets a Complete Response Letter for UX111 - Insider Monkey
Is Ultragenyx Pharmaceutical Inc. a good long term investmentConsistently high returns - jammulinksnews.com
1.69%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):